AG000MSC

124832-27-5 | L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester,monohydrochloride

AG000MSC

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	124832-27-5
Catalog Number	AG000MSC(AGN-PC-0PHVO3)
Chemical Name	L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester,monohydrochloride
IUPAC Name	2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochloride
InChI	InChI=1S/C13H20N6O4.ClH/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20;/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20);1H/t8-;/m0./s1
InChI Key	ZCDDBUOENGJMLV-QRPNPIFTSA-N
MDL Number	MFCD28977550
Molecular Formula	C13H21ClN6O4
Molecular Weight	360.7966
NSC Number	759101
SMILES	N[C@@H](C(C)C)C(OCCOCN1C=NC2=C1NC(N)=NC2=O)=O.[H]Cl
UNII	G447S0T1VC
Synonyms	2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate, 256U87, Acyclovir, L valyl Ester, acyclovir, L-valyl ester, BW256U87, D- Valacyclovir, L Valylacyclovir, L-valyl Ester Acyclovir, L-valylacyclovir, valaciclovir, valacyclovir, valacyclovir hydrochloride, valacyclovir hydrochloride, (DL)-isomer, valacyclovir, (D)-isomer, valacyclovir, (DL)-isomer, valacyclovir, (L)-isomer, Valacyclovir, D-, valacyclovir, x-hydrochloride, (D)-isomer, valacyclovir, x-hydrochloride, (DL)-isomer, Valtrex, Valacyclovir hydrochloride, 124832-27-5, Valaciclovir Hcl, Valacyclovir HCl, Valaciclovir hydrochloride, 256U87 hydrochloride, Valacyclovir (hydrochloride), UNII-G447S0T1VC, BW-256U87, C13H20N6O4.HCl, CHEBI:9919, G447S0T1VC, Valacyclovir hydrochloride [USAN], Valtrex (TN), BW 256, L-Valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride, DSSTox_CID_24210, DSSTox_RID_80121, DSSTox_GSID_44210, Valacyclovir hydrochloride (USAN), L-Valacyclovir Hydrochloride, 2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate hydrochloride, 256U87 HCl, L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester, monohydrochloride, (S)-2-((2-AMINO-6-OXO-1H-PURIN-9(6H)-YL)METHOXY)ETHYL 2-AMINO-3-METHYLBUTANOATE HYDROCHLORIDE, 256u, BW256U87, CAS-124832-27-5, BW 256U87, NCGC00159520-02, L-valylacyclovir, L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, monohydrochloride, MFCD01861507, Valacyclovir hydrochloride [USAN:USP], 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate, acyclovir, L-valyl ester, AC1L1TW2, AC1Q3EH7, SureCN1888797, SureCN5665934, SCHEMBL40830, MLS001401440, SPECTRUM1505368, Valaciclovir Hydrochloride,(S), CHEMBL1201110, DTXSID2044210, ZCDDBUOENGJMLV-QRPNPIFTSA-N, HMS1922F20, Pharmakon1600-01505368, Valaciclovir hydrochloride (JP17), BCP06722, Tox21_111738, HY-17425A, NSC759101, s1876, AKOS008901386, AKOS015951215, Tox21_111738_1, AC-8065, AN-8355, API0004558, CCG-100889, CCG-213402, CS-1966, H32V264, KS-1126, NC00139, NSC-759101, L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride, NCGC00178638-02, BC202740, CPD000469208, SAM001246749, SMR000469208, AB0012705, AB1009371, LS-172602, FT-0631117, SW197519-2, V0111, C07184, D00398, Valaciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard, Valaciclovir hydrochloride (anhydrous), European Pharmacopoeia (EP) Reference Standard, Valacyclovir HCl, Pharmaceutical Secondary Standard; Certified Reference Material, Valacyclovir hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester monohydrochloride; L-Valine; Valtrex, 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate hydrochloride, 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate hydrochloride, L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, hydrochloride (1:1), Valtrex, valacyclovir, Zelitrex, hydrochloride, Valaciclovir, ValACV, D05MFA, Valacyclovir hydrochloride hydrate, CID60772, DRG-0119, C13-H20-N6-O4.Cl-H, CS-O-08374, B1030, B2061, Valacyclovir hydrochloride, 98%, HSV antagonist - 250MG 250mg, (S)-2-[(2-Amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl-2-amino-3-methylbutanoate, 124832-26-4, 136489-37-7,

Complexity	483
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	360.131g/mol
Formal Charge	0
Heavy Atom Count	24
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	360.799g/mol
Monoisotopic Mass	360.131g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	147A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number